Cited by 21Heat shock proteins researchCell death mechanisms and regulationCancer-related Molecular Pathways

Association of Nuclear-Localized Nemo-Like Kinase with Heat-Shock Protein 27 Inhibits Apoptosis in Human Breast Cancer Cells

Open access
Shaw-Hallgren, Gina, Chmielarska Masoumi, Katarzyna, Zarrizi, Reihaneh, Hellman, Ulf, Karlsson, Per, Helou, Khalil, Massoumi, Ramin·2014·PLoS ONE

Abstract

Nemo-like kinase (NLK), a proline-directed serine/threonine kinase regulated by phosphorylation, can be localized in the cytosol or in the nucleus. Whether the localization of NLK can affect cell survival or cell apoptosis is yet to be disclosed. In the present study we found that NLK was mainly localized in the nuclei of breast cancer cells, in contrast to a cytosolic localization in non-cancerous breast epithelial cells. The nuclear localization of NLK was mediated through direct interaction with Heat shock protein 27 (HSP27) which further protected cancer cells from apoptosis. The present study provides evidence of a novel mechanism by which HSP27 recognizes NLK in the breast cancer cells and prevents NLK-mediated cell apoptosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0096506

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In breast cancer, NLK is mainly localised in the nuclei of breast cancer cells compared to the cytosolic localisation in non-cancerous breast epithelial cells.

    “In breast cancer, NLK was found to be mainly localised in the nuclei of breast cancer cells compared to the cytosolic localisation in non-cancerous breast epithelial cells.”
  • The interaction between HSP27 and NLK mediates nuclear localisation and protects cancer cells from apoptosis.

    “The interaction between heat shock protein 27 (HSP27) and NLK mediated the nuclear localisation and protected the cancer cells from apoptosis [29].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. [2]Kanei-Ishii C, Ninomiya-Tsuji J, Tanikawa J, Nomura T, Ishitani T, et al (2004) Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes & Development 18: 816– 829. 15082531 PMC387421
  2. [3]Kanei-Ishii C, Nomura T, Tanikawa J, Ichikawa-Iwata E, Ishii S (2004) Differential sensitivity of v-Myb and c-Myb to Wnt-1-induced protein degradation. Journal of Biological Chemistry 279: 44582– 44589. 15308626
  3. [4]Kurahashi T, Nomura T, Kanei-Ishii C, Shinkai Y, Ishii S (2005) The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3. Molecular Biology of the Cell 16: 4705– 4713. 16055500 PMC1237076
  4. [5]Kanei-Ishii C, Nomura T, Takagi T, Watanabe N, Nakayama KI, et al (2008) Fbxw7 Acts as an E3 Ubiquitin Ligase That Targets c-Myb for Nemo-like Kinase (NLK)-induced Degradation. Journal of Biological Chemistry 283: 30540– 30548. 18765672 PMC2662147
  5. [6]Meneghini MD, Ishitani T, Carter JC, Hisamoto N, Ninomiya-Tsuji J, et al (1999) MAP kinase and Wnt pathways converge to downregulate an HMG-domain repressor in Caenorhabditis elegans. Nature 399: 793– 797. 10391246
  6. [8]Ohnishi E, Goto T, Sato A, Kim M, Iemura S, et al (2010) Nemo-Like Kinase, an Essential Effector of Anterior Formation, Functions Downstream of p38 Mitogen-Activated Protein Kinase. Molecular and Cellular Biology 30: 675– 683. 19933839 PMC2812222
  7. [10]Smit L, Baas A, Kuipers J, Korswagen H, van de Wetering M, et al (2004) Wnt activates the Tak1/Nemo-like kinase pathway. Journal of Biological Chemistry 279: 17232– 17240. 14960582
  8. [12]Ishitani T, Hirao T, Suzuki M, Isoda M, Ishitani S, et al Nemo-like kinase suppresses Notch signalling by interfering with formation of the Notch active transcriptional complex. Nature Cell Biology 12: 278– 285. 20118921
  9. [13]Zeng YA, Rahnama M, Wang S, Sosu-Sedzorme W, Verheyen EM (2007) Drosophila Nemo antagonizes BMP signaling by phosphorylation of Mad and inhibition of its nuclear accumulation. Development 134: 2061– 2071. 17507407
  10. [14]Yamada M, Ohnishi J, Ohkawara B, Iemura S, Satoh K, et al (2006) NARF, an nemo-like kinase (NLK)-associated ring finger protein regulates the ubiquitylation and degradation of T cell factor/lymphoid enhancer factor (TCF/LEF). Journal of Biological Chemistry 281: 20749– 20760. 16714285
  11. [15]Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, et al (2007) A histone lysine methyltransferase activated by non- canonical Wnt signalling suppresses PPAR-gamma transactivation. Nature Cell Biology 9: 1273– 1285. 17952062
  12. [16]Li M, Wang H, Huang T, Wang JY, Ding Y, et al (2010) TAB2 Scaffolds TAK1 and NLK in Repressing Canonical Wnt Signaling. Journal of Biological Chemistry 285: 13397– 13404. 20194509 PMC2859499
  13. [17]Nifuji A, Ideno H, Ohyama Y, Takanabe R, Araki R, et al (2010) Nemo-like kinase (NLK) expression in osteoblastic cells and suppression of osteoblastic differentiation. Experimental Cell Research 316: 1127– 1136. 20116374
  14. [18]Takada I, Kouzmenko AP, Kato S (2009) Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapies. Expert Opinion on Therapeutic Targets 13: 593– 603. 19397478
  15. [19]Ohnishi E, Goto T, Sato A, Kim MS, Iemura S, et al (2010) Nemo-like kinase, an essential effector of anterior formation, functions downstream of p38 mitogen-activated protein kinase. Mol Cell Biol 30: 675– 683. 19933839 PMC2812222
  16. [20]Kojima H, Sasaki T, Ishitani T, Iemura S, Zhao H, et al (2005) STAT3 regulates Nemo-like kinase by mediating its interaction with IL-6-stimulated TGF beta-activated kinase 1 for STAT3 Ser-727 phosphorylation. Proceedings of the National Academy of Sciences of the United States of America 102: 4524– 4529. 15764709 PMC555521
  17. [21]Ohkawara B, Shiratake K, Hyodo-Miura J, Matsuo R, Ueno N, et al (2004) Role of the TAK1-NLK-STAT3 pathway in TGF-beta-mediated mesoderm induction. Genes & Development 18: 381– 386. 15004007 PMC359392
  18. [22]Kim S, Kim Y, Lee J, Chung J (2010) Regulation of FOXO1 by TAK1-Nemo-like Kinase Pathway. Journal of Biological Chemistry 285: 8122– 8129. 20061393 PMC2832963
  19. [23]Satoh K, Ohnishi J, Sato A, Takeyama M, Iemura SI, et al (2007) Nemo-like kinase-myocyte enhancer factor 2A signaling regulates anterior formation in xenopus development. Molecular and Cellular Biology 27: 7623– 7630. 17785444 PMC2169051
  20. [24]Ishitani T, Ishitani S, Matsumoto K, Itoh M (2009) Nemo-like kinase is involved in NGF-induced neurite outgrowth via phosphorylating MAP1B and paxillin. Journal of Neurochemistry 111: 1104– 1118. 19840224
  21. [25]Yasuda J, Tsuchiya A, Yamada T, Sakamoto M, Sekiya T, et al (2003) Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells. Biochemical and Biophysical Research Communications 308: 227– 233. 12901858
  22. [26]Yasuda J, Yokoo H, Yamada T, Kitabayashi I, Sekiya T, et al (2004) Nemo-like kinase suppresses a wide range of transcription factors, including nuclear factor-kappa B. Cancer Science 95: 52– 57. 14720327 PMC11158368
  23. [27]Emami KH, Brown LG, Pitts TEM, Sun XZ, Vessella RL, et al (2009) Nemo-Like Kinase Induces Apoptosis and Inhibits Androgen Receptor Signaling in Prostate Cancer Cells. Prostate 69: 1481– 1492. 19514049 PMC2908180
  24. [28]Jung KH, Kim JK, Noh JH, Fun JW, Bae HJ, et al (2010) Targeted Disruption of Nemo-Like Kinase Inhibits Tumor Cell Growth by Simultaneous Suppression of Cyclin D1 and CDK2 in Human Hepatocellular Carcinoma. Journal of Cellular Biochemistry 110: 687– 696. 20512928
  25. [29]Ishitani S, Inaba K, Matsumoto K, Ishitani T (2011) Homodimerization of Nemo-like kinase is essential for activation and nuclear localization. Mol Biol Cell 22: 266– 277. 21118996 PMC3020921
  26. [30]Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850– 858. 8779443
  27. [31]Hellman U, Bhikhabhai R (2002) Easy amino acid sequencing of sulfonated peptides using post-source decay on a matrix-assisted laser desorption/ionization time-of-flight mass spectrometer equipped with a variable voltage reflector. Rapid Commun Mass Spectrom 16: 1851– 1859. 12271450
  28. [32]Brott BK, Pinsky BA, Erikson RL (1998) Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus. Proceedings of the National Academy of Sciences of the United States of America 95: 963– 968. 9448268 PMC18639
  29. [33]Kampinga HH, Brunsting JF, Stege GJJ, Konings AWT, Landry J (1994) cells overexpressing HSP27 show accelerated recovery from heat-induced nuclear protein aggregation. Biochemical and Biophysical Research Communications 204: 1170– 1177. 7980592
  30. [34]Geum D, Son GH, Kim K (2002) Phosphorylation-dependent cellular localization and thermoprotective role of heat shock protein 25 in hippocampal progenitor cells. Journal of Biological Chemistry 277: 19913– 19921. 11912188
  31. [35]Emami KH, Brown LG, Pitts TE, Sun X, Vessella RL, et al (2009) Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells. Prostate 69: 1481– 1492. 19514049 PMC2908180
  32. [36]Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, et al (2007) A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol 9: 1273– 1285. 17952062
  33. [37]Kostenko S, Moens U (2009) Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci 66: 3289– 3307. 19593530 PMC11115724
  34. [38]Hansen RK, Parra I, Lemieux P, Oesterreich S, Hilsenbeck SG, et al (1999) Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells. Breast Cancer Res Treat 56: 187– 196. 10573111
  35. [39]Kang SH, Kang KW, Kim KH, Kwon B, Kim SK, et al (2008) Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability. BMC Cancer 8: 286. 18834540 PMC2567332
  36. [40]Williams K, Chubb C, Huberman E, Giometti CS (1998) Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines. Electrophoresis 19: 333– 343. 9548300
  37. [41]Myung JK, Afjehi-Sadat L, Felizardo-Cabatic M, Slavc I, Lubec G (2004) Expressional patterns of chaperones in ten human tumor cell lines. Proteome Sci 2: 8. 15598346 PMC543454
  38. [42]Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SA (1993) Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J Natl Cancer Inst 85: 1558– 1570. 8411230
  39. [43]Pannem RR, Dorn C, Ahlqvist K, Bosserhoff AK, Hellerbrand C, et al (2014) CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma. Carcinogenesis. 35: 461– 468. 24104553

Cited by

Sorted by citations

Authors
Shaw-Hallgren, G., Chmielarska Masoumi, K., Zarrizi, R., Hellman, U., Karlsson, P., Helou, K., & Massoumi, R.
Affiliations
  • Lund University (SE)
  • Ludwig Cancer Research (SE)
  • University of Gothenburg (SE)
Corresponding author
Massoumi, Ramin
Venue
PLoS ONE
Published
2014-05-09
Volume
9
Issue
5
Pages
e96506
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2032845032
Cited by
21
References
4
Citations by year
2024: 1 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 2 · 2016: 5 · 2015: 3 · 2014: 1
FWCI
1.23
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion, other-oa)
Funders
  • Swedish Cancer Foundation
  • European Commission
  • Kungliga Fysiografiska Sällskapet i Lund
  • Magnus Bergvalls Stiftelse
  • Medical Research Council
  • FP7 Ideas: European Research Council (260460)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
Nemo-like kinase, HSP27, nuclear localization, apoptosis, breast cancer, cytosolic kinase, cell survival
MeSH terms
Antineoplastic Agents, Phytogenic, Breast Neoplasms, Cell Line, Cell Nucleus, Cytoplasm, Etoposide, Female, Heat-Shock Proteins, Humans, Immunohistochemistry, Mutation, Phosphorylation, Protein Binding, Tumor Necrosis Factor-alpha, Blotting, Western, Down-Regulation, Apoptosis, Protein Serine-Threonine Kinases, Microscopy, Confocal, Molecular Chaperones, RNA Interference, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, HSP27 Heat-Shock Proteins, MCF-7 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review